865 related articles for article (PubMed ID: 2843005)
1. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
Persson E
Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro release of lipoprotein lipase and hepatic lipase by low molecular weight heparins.
Meraihi Z; Lutz O; Frey A; Bach AC
Arch Int Pharmacodyn Ther; 1989; 297():286-93. PubMed ID: 2543347
[TBL] [Abstract][Full Text] [Related]
3. Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment.
Persson E; Nordenström J; Nilsson-Ehle P
Scand J Clin Lab Invest; 1987 Apr; 47(2):151-5. PubMed ID: 3576117
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment.
Persson E; Nordenström J; Nilsson-Ehle P; Hagenfeldt L; Wahren J
Clin Physiol; 1990 Nov; 10(6):573-83. PubMed ID: 1964632
[TBL] [Abstract][Full Text] [Related]
5. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
Harenberg J; Stehle G; Dempfle CE; von Hodenberg E; Heene DL
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):967-80. PubMed ID: 2483715
[TBL] [Abstract][Full Text] [Related]
6. Release of lipoprotein lipase and hepatic lipase activities. Effects of heparin and a low molecular weight heparin fragment.
Persson E; Nilsson-Ehle P
Scand J Clin Lab Invest; 1990 Feb; 50(1):43-9. PubMed ID: 2156335
[TBL] [Abstract][Full Text] [Related]
7. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
Brodin E; Svensson B; Paulssen RH; Nordoy A; Hansen JB
J Lab Clin Med; 2004 Nov; 144(5):246-53; discussion 226-7. PubMed ID: 15570242
[TBL] [Abstract][Full Text] [Related]
8. Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin.
Persson E; Nordenström J; Nilsson-Ehle P; Hagenfeldt L
Eur J Clin Invest; 1985 Aug; 15(4):215-20. PubMed ID: 3930257
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment.
Persson E; Nordenström J; Hagenfeldt L; Nilsson-Ehle P
Thromb Res; 1987 Jun; 46(5):697-704. PubMed ID: 3629543
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
Grimaudo V; Omri A; Kruithof EK; Hauert J; Bachmann F
Thromb Haemost; 1988 Jun; 59(3):388-91. PubMed ID: 2847348
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth hormone on lipoprotein lipase and hepatic lipase.
Oscarsson J; Ottosson M; Edén S
J Endocrinol Invest; 1999; 22(5 Suppl):2-9. PubMed ID: 10442563
[TBL] [Abstract][Full Text] [Related]
12. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T
Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889
[TBL] [Abstract][Full Text] [Related]
13. [Effect of the intravenous administration of homologous albumin on the lipolytic enzyme activity of rabbit blood plasma].
Soliternova IB; Nikul'cheva NG; Sanches Serrano D
Vopr Med Khim; 1984; 30(2):87-91. PubMed ID: 6740999
[TBL] [Abstract][Full Text] [Related]
14. Influence of trauma on plasma elimination of exogenous fat and on lipoprotein lipase activity and mass.
Thörne A; Aberg W; Carneheim C; Olivecrona T; Nordenström J
Clin Nutr; 2005 Feb; 24(1):66-74. PubMed ID: 15681103
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lipolysis and lipoprotein lipase after weight loss in obese, postmenopausal women.
Berman DM; Nicklas BJ; Ryan AS; Rogus EM; Dennis KE; Goldberg AP
Obes Res; 2004 Jan; 12(1):32-9. PubMed ID: 14742840
[TBL] [Abstract][Full Text] [Related]
16. Post-heparin lipolytic activity in acute renal failure.
Druml W; Zechner R; Magometschnigg D; Lenz K; Kleinberger G; Laggner A; Kostner G
Clin Nephrol; 1985 Jun; 23(6):289-93. PubMed ID: 4028526
[TBL] [Abstract][Full Text] [Related]
17. Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme.
Nasstrom B; Stegmayr BG; Olivecrona G; Olivecrona T
J Lab Clin Med; 2003 Aug; 142(2):90-9. PubMed ID: 12960955
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients.
Richelsen B; Pedersen SB; Kristensen K; Børglum JD; Nørrelund H; Christiansen JS; Jørgensen JO
Metabolism; 2000 Jul; 49(7):906-11. PubMed ID: 10910003
[TBL] [Abstract][Full Text] [Related]
20. Effects of tiadenol and clofibrate on plasma post heparin lipolytic hepatic, extrahepatic and monoglyceride hydrolase activities in rats with hypertriglyceridemia induced by a sucrose rich diet.
Gutman R; Basílico MZ; Chicco A; de Rodi MA; Nusimovich B; Lombardo YB
Horm Metab Res; 1985 Apr; 17(4):169-75. PubMed ID: 4007766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
